Dirk Schadendorf Selected Research

Vaccines

5/2023	Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy.
1/2017	Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.
6/2010	Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine.
7/2008	Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.
1/2007	Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy.
11/2005	A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
10/2005	Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
3/2002	Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Schadendorf Research Topics

Disease

440	Melanoma (Melanoma, Malignant) 04/2024 - 01/2002
269	Neoplasms (Cancer) 05/2024 - 01/2002
88	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2002
37	Disease Progression 05/2024 - 06/2004
28	Skin Neoplasms (Skin Cancer) 05/2023 - 01/2002
20	Brain Neoplasms (Brain Tumor) 09/2023 - 02/2008
19	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 03/2007
16	Merkel Cell Carcinoma 12/2023 - 01/2017
8	Uveal melanoma 10/2023 - 05/2013
8	Exanthema (Rash) 10/2023 - 06/2011
8	Lymphatic Metastasis 05/2023 - 08/2003
8	Inflammation (Inflammations) 01/2022 - 10/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 12/2012
7	Basal Cell Carcinoma (Rodent Ulcer) 12/2022 - 08/2014
7	Neutropenia 01/2021 - 11/2012
6	Fatigue 03/2024 - 06/2009
6	Nausea 10/2023 - 06/2011
6	Fever (Fevers) 01/2023 - 11/2014
6	Hypertension (High Blood Pressure) 11/2022 - 01/2017
6	Body Weight (Weight, Body) 10/2019 - 01/2010
6	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2008
6	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2008 - 04/2003
5	Dermatitis 03/2024 - 03/2010
5	Diarrhea 10/2023 - 06/2009
5	COVID-19 01/2023 - 01/2021
5	Infections 01/2021 - 07/2006
5	Colitis 11/2019 - 08/2015
5	Arthralgia (Joint Pain) 10/2018 - 06/2011
5	Keratoacanthoma 01/2018 - 11/2010
4	Pain (Aches) 02/2024 - 05/2015

Drug/Important Bio-Agent (IBA)

85	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
57	IpilimumabIBA 12/2023 - 02/2010
55	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2024 - 02/2007
50	AntigensIBA 01/2023 - 01/2002
49	NivolumabIBA 03/2024 - 01/2015
45	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2005
44	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2002
39	pembrolizumabIBA 03/2024 - 01/2015
33	dabrafenibIBA 09/2023 - 11/2012
32	trametinibIBA 10/2023 - 07/2012
30	VemurafenibIBA 04/2024 - 11/2010
25	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2002
22	Peptides (Polypeptides)IBA 01/2020 - 03/2002
21	AntibodiesIBA 01/2022 - 03/2004
18	LigandsIBA 01/2023 - 03/2004
17	Neoplasm Antigens (Tumor Antigens)IBA 11/2021 - 03/2002
17	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 09/2005
16	InterferonsIBA 01/2023 - 09/2008
16	EpitopesIBA 10/2021 - 03/2002
15	binimetinibIBA 04/2024 - 03/2013
15	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022 - 03/2002
14	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023 - 12/2007
14	Phosphotransferases (Kinase)IBA 01/2023 - 08/2004
13	CytokinesIBA 01/2023 - 01/2002
13	Messenger RNA (mRNA)IBA 01/2023 - 07/2002
12	encorafenibIBA 04/2024 - 01/2018
12	Cisplatin (Platino)FDA LinkGeneric 03/2016 - 03/2002
10	Monoclonal AntibodiesIBA 03/2024 - 04/2003
9	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2015
9	Mitogen-Activated Protein KinasesIBA 05/2019 - 02/2011
8	cemiplimabIBA 03/2024 - 01/2018
8	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2017
8	VaccinesIBA 05/2023 - 03/2002
8	B7-H1 AntigenIBA 01/2023 - 01/2017
8	Differentiation AntigensIBA 01/2022 - 08/2004
7	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023 - 03/2013
7	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023 - 01/2013
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2011
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2012
7	Interferon-alpha (Interferon Alfa)IBA 01/2014 - 08/2003
6	relatlimabIBA 10/2023 - 01/2022
6	HhAntag691IBA 04/2022 - 08/2014
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2009
6	Adenosine Triphosphate (ATP)IBA 02/2021 - 07/2003
6	Complementary DNA (cDNA)IBA 12/2019 - 03/2003
6	MART-1 AntigenIBA 01/2018 - 08/2004
6	EnzymesIBA 01/2017 - 01/2003
6	AutoantibodiesIBA 09/2013 - 01/2007
6	Etoposide (VP 16)FDA LinkGeneric 12/2006 - 03/2002
5	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2023 - 05/2002
5	Lipase (Acid Lipase)FDA Link 10/2023 - 11/2012
5	TransducinIBA 01/2020 - 03/2007
5	Microphthalmia-Associated Transcription FactorIBA 01/2019 - 11/2007
5	Interferon alpha-2 (Roferon-A)FDA Link 05/2018 - 08/2003
5	ParaffinIBA 01/2018 - 04/2007
5	Interleukin-2 (IL2)IBA 12/2015 - 03/2002
5	HLA-DR Antigens (HLA-DR)IBA 03/2014 - 06/2004
5	Vindesine (Vindesin)IBA 12/2011 - 03/2002
5	HLA-A*02:01 antigenIBA 10/2010 - 05/2002
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 11/2006
4	CTLA-4 AntigenIBA 12/2020 - 02/2010
4	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 03/2007

Therapy/Procedure

226	Therapeutics 05/2024 - 03/2002
87	Immunotherapy 04/2024 - 01/2002
30	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
16	Radiotherapy 10/2022 - 05/2004
9	Aftercare (After-Treatment) 05/2023 - 04/2007
8	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 02/2008
4	Metastasectomy 03/2022 - 10/2008
4	Retreatment 01/2021 - 04/2013